Procaps Group to Host Webinar on Colombian Pharma Market

Rhea-AI Summary

Procaps Group (NASDAQ: PROC) will host a webinar on October 10th to discuss the Colombian pharma market and its regulations. The webinar will be led by Mariana Sarasti, Director of Pharmaceutical Industry Chamber within the National Business Association of Colombia (ANDI).

The Webinar will occur on Tuesday, October 10, 2023 at 10:00 a.m. Eastern Time

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)-- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical services company, announced that it will host a webinar dedicated to the Colombian pharma market and its regulations on October 10^th.

The Company will host a webinar at 10:00 a.m. Eastern time with Mariana Sarasti, Director of Pharmaceutical Industry Chamber within the National Business Association of Colombia (ANDI).

Mariana is an economist from The Chicago University, with a specialization in social economics from Universidad de los Andes and a master’s degree in public administration from Harvard University. She has extensive experience in business development and strategy, as well as in project planning and management in the public and private sectors.

To access the webinar, please use the following information:

Date:	Tuesday, October 10, 2023
Time:	10:00 a.m. ET
Webinar Link:	click here

The webinar will be broadcast live and available for replay via the investor relations section of Procaps’ website here.

About Procaps Group

Procaps Group, S.A. (“Procaps”) (NASDAQ: PROC) is a leading developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5,500 employees working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions.

For more information, visit Procaps’ investor relations website investor.procapsgroup.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231002527710/en/

Investor Contact:

Melissa Angelini

ir@procapsgroup.com

investor.procapsgroup.com

Source: Procaps Group